Contraindicated. Coadministration of doravirine with a solid CYP3A inducer may minimize doravirine plasma concentrations and/or effects. Potential for lack of virologic response and probable resistance to doravirine. pentobarbital will reduce the extent or impact of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown. pentobarbital will mini... https://abduls987ixm4.techionblog.com/profile